Showing results (61-70 of 125) with videos related to
Sort By:
Pageof 13
Journal of Substance Abuse Treatment|June 30, 2022
Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomesAmanda M Bunting, Noa Krawczyk, Tse-Hwei Choo, et al.Drug and Alcohol Dependence|May 19, 2018
How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysisFrances R Levin, C Jean Choi, Martina Pavlicova, et al.Journal of Addiction Medicine|May 18, 2026
A Comparison of Neuropsychological Functioning Between Patients With Opioid Use Disorder Treated With Extended-Release Naltrexone or Buprenorphine-NaloxoneFelipe Castillo, Aimee N C Campbell, Tse-Hwei Choo, et al.The American Journal on Addictions|January 5, 2017
Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependenceDaniel P Notzon, John J Mariani, Martina Pavlicova, et al.Addiction (Abingdon, England)|January 10, 2013
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disordersFrances R Levin, John Mariani, Daniel J Brooks, et al.Drug and Alcohol Dependence Reports|July 3, 2023
Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory studyWilfrid Noël Raby, Matthew Heller, Demetrios Milliaressis, et al.Psychosomatic Medicine|December 18, 2020
The Impact of Aerobic Training on Cardiovascular Reactivity to and Recovery From Psychological and Orthostatic ChallengeRichard P Sloan, Peter A Shapiro, Vincenzo Lauriola, et al.Pediatric Cardiology|June 27, 2019
Utility of 3D Printed Cardiac Models for Medical Student Education in Congenital Heart Disease: Across a Spectrum of Disease SeverityJennifer Smerling, Charles C Marboe, Jay H Lefkowitch, et al.The American Journal of Drug and Alcohol Abuse|August 28, 2020
Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in CaucasiansMatthew Randesi, John Rotrosen, Edward V Nunes, et al.The American Journal of Drug and Alcohol Abuse|February 9, 2018
Open-label pilot study of injectable naltrexone for cannabis dependenceDaniel P Notzon, Meredith A Kelly, C Jean Choi, et al.Pageof 13